Stockholders’ Equity (Details Narrative) - USD ($) |
Sep. 28, 2022 |
Jun. 30, 2023 |
Jun. 30, 2022 |
May 04, 2021 |
|---|---|---|---|---|
| Subsidiary, Sale of Stock [Line Items] | ||||
| Common stock, shares authorized | 40,000,000 | 40,000,000 | ||
| Common stock, par value | $ 0.001 | $ 0.001 | ||
| Preferred stock, shares authorized | 2,000,000 | 0 | ||
| Preferred stock, par value | $ 0.001 | $ 0.001 | ||
| Private Placement [Member] | ||||
| Subsidiary, Sale of Stock [Line Items] | ||||
| Stock issued during period, shares, new issues | 2,264,650 | |||
| Stock issued during period, value, new issues | $ 6,647,000 | |||
| Stock issued value per unit | $ 2.935 | |||
| Proceeds from issuance or sale of equity | $ 6,330,000 | |||
| Net proceeds after deducting financing fees | $ 317,000 | |||
| Warrant exercise price per share | $ 4.215 | |||
| IPO [Member] | ||||
| Subsidiary, Sale of Stock [Line Items] | ||||
| Common stock, shares authorized | 40,000,000 | |||
| Common stock, par value | $ 0.001 | |||
| Preferred stock, shares authorized | 2,000,000 | |||
| Preferred stock, par value | $ 0.001 |
| X | ||||||||||
- Definition Net proceeds after deducting financing fees. No definition available.
|
| X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of common stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|